Refile: TABLE-Sawai Pharmaceutical - 9-MTH group results

SAWAI group

13/02/2018 06:21

(Adds company forecast. Accounting policy for forecast is IFRS) 
Feb 13 (Reuters)-  
Sawai Pharmaceutical Co Ltd  
CONSOLIDATED FINANCIAL HIGHLIGHTS 
(in billions of yen unless specified) 
 
                   9 months ended      9 months ended       Year to 
                  Dec 31, 2017        Dec 31, 2016     Mar 31, 2018 
                     LATEST             YEAR-AGO          LATEST 
                     RESULTS             RESULTS         FORECAST 
  Sales              116.54              101.38           168.80 
                   (+15.0 pct)         (+9.7 pct) 
  Operating           19.10               17.90            23.70 
                   (+6.7 pct)          (-7.4 pct) 
  Recurring           19.67               17.87            23.30 
                   (+10.1 pct)         (-6.5 pct) 
  Net                 14.04               13.69            12.80 
                   (+2.6 pct)          (-2.2 pct) 
  EPS              377.01 yen          371.35 yen       343.59 yen 
  EPS Diluted      376.76 yen          371.13 yen 
  Ann Div                              130.00 yen       130.00 yen 
  -Q2 div           65.00 yen           65.00 yen 
  -Q4 div                               65.00 yen        65.00 yen 
 
NOTE - Sawai Pharmaceutical Co Ltd. 
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4555.T ((Tokyo 
Headline News Desk +813 6441 1812))